Consequently, we selected MCF-7 and MDA-MB-361 cells, which display an ERα-positive/PR-positive/HER2-negative and an ERα-positive/PR-negative/HER2-positive phenotype, respectively, to further validate the impact of these kinases on ERα stability and BC cell proliferation. This evidence concerns the gene ERBB2 and breast cancer.